X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2193) 2193
Publication (406) 406
Book Review (23) 23
Newsletter (20) 20
Book Chapter (16) 16
Magazine Article (9) 9
Conference Proceeding (7) 7
Trade Publication Article (4) 4
Newspaper Article (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1562) 1562
index medicus (1420) 1420
raltegravir (1338) 1338
hiv infections - drug therapy (1099) 1099
infectious diseases (903) 903
raltegravir potassium (779) 779
hiv (737) 737
male (716) 716
female (672) 672
adult (597) 597
pharmacology & pharmacy (540) 540
immunology (534) 534
hiv infections - virology (530) 530
middle aged (526) 526
hiv-1 - drug effects (488) 488
virology (461) 461
antiretroviral therapy (416) 416
anti-hiv agents - therapeutic use (406) 406
antiviral agents (400) 400
microbiology (394) 394
pyrrolidinones - therapeutic use (341) 341
infection (332) 332
hiv infection (331) 331
viral load (331) 331
hiv integrase inhibitors - pharmacology (301) 301
drug therapy (297) 297
hiv-1 - genetics (294) 294
hiv integrase inhibitors - therapeutic use (291) 291
treatment outcome (286) 286
integrase (276) 276
hiv-1 (272) 272
double-blind (260) 260
human immunodeficiency virus--hiv (259) 259
anti-hiv agents - administration & dosage (256) 256
aids/hiv (254) 254
therapy (250) 250
pharmacokinetics (242) 242
safety (242) 242
drug resistance, viral (241) 241
efficacy (237) 237
cd4 lymphocyte count (221) 221
dolutegravir (221) 221
antiretroviral drugs (216) 216
pyrrolidinones - pharmacology (210) 210
drug therapy, combination (207) 207
resistance (207) 207
pyrrolidinones - administration & dosage (206) 206
hiv integrase - genetics (194) 194
research (193) 193
mutation (191) 191
anti-hiv agents - pharmacology (188) 188
elvitegravir (187) 187
drug resistance (183) 183
analysis (182) 182
highly active antiretroviral therapy (179) 179
aids (178) 178
anti-hiv agents - adverse effects (176) 176
health aspects (176) 176
integrase inhibitor (176) 176
integrase inhibitors (172) 172
replication (167) 167
dosage and administration (165) 165
protease inhibitors (163) 163
drug interactions (161) 161
pyrrolidinones - adverse effects (161) 161
hiv infections - immunology (158) 158
article (157) 157
young adult (155) 155
raltegravir intensification (153) 153
tenofovir (148) 148
hiv-1 - enzymology (146) 146
hiv integrase - metabolism (145) 145
antiretroviral therapy, highly active (144) 144
darunavir (141) 141
immunodeficiency-virus type-1 (141) 141
efavirenz (140) 140
hiv integrase inhibitors - adverse effects (138) 138
hiv-1 - isolation & purification (135) 135
human immunodeficiency virus (133) 133
rna, viral - blood (132) 132
care and treatment (130) 130
hiv-1 integrase (127) 127
virus diseases (127) 127
hiv integrase inhibitors - administration & dosage (126) 126
once-daily dolutegravir (126) 126
ritonavir (126) 126
in-vitro (125) 125
inhibitors (124) 124
emtricitabine (123) 123
hiv-1-infected patients (123) 123
raltegravir potassium - therapeutic use (123) 123
active antiretroviral therapy (122) 122
animals (121) 121
pyrrolidinones - pharmacokinetics (121) 121
drug resistance, viral - genetics (120) 120
drug-resistance (120) 120
combination therapy (119) 119
aged (118) 118
antiretroviral agents (118) 118
hiv-1 - physiology (118) 118
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2126) 2126
Spanish (53) 53
German (26) 26
French (15) 15
Japanese (5) 5
Chinese (4) 4
Russian (4) 4
Czech (1) 1
Dutch (1) 1
Italian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


AIDS, ISSN 0269-9370, 08/2017, Volume 31, Issue 13, pp. 1853 - 1858
Journal Article
Journal Article
Journal of Pharmaceutical and Biomedical Analysis, ISSN 0731-7085, 01/2020, Volume 177, p. 112838
Raltegravir (RAL) is a HIV-integrase inhibitor recommended for treatment of HIV type 1 infection during pregnancy. The elimination of RAL to RAL glucuronide... 
Pregnancy | LC–MS/MS | Raltegravir glucuronide | Raltegravir
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 2015, Volume 61, Issue 5, pp. 809 - 816
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 08/2014, Volume 210, Issue 3, pp. 354 - 362
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9692, pp. 796 - 806
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 4, pp. 355 - 365
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2008, Volume 359, Issue 4, pp. 339 - 354
Journal Article
Journal of Clinical Virology, ISSN 1386-6532, 2016, Volume 87, pp. 30 - 36
Journal Article